semaglutide ckd approval In the FLOW trial, researchers assessed whether the glucagon-like peptide 1 receptor agonist was effective in preventing progression of kidney disease in patients with type 2 diabetes and chronic kidney disease Recent medical milestones include the

P., Leiter, L

Urinary tract infections can affect any part of the urinary system, including the kidneys, ureters, bladder, and urethra, though most infections involve the lower urinary tract (bladder and urethra)

[1] Timeline of nausea experience: Initial weeks: Nausea often most intense, particularly after the first few injections Subsequent weeks: Symptoms typically begin to improve as the body adapts Beyond initial adaptation: Most patients experience significant reduction or resolution Longer term: A minority of patients may experience persistent symptoms Clinical experience suggests that while many patients see improvement within 4-8 weeks, the exact timeline varies considerably between individuals

Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial): This study showed that tirzepatide can lead to significant weight loss during active treatment compared with placebo

July 20, 2026 What Is the Best Time of Day to Take a Statin

Non-injectable treatment formats are becoming a strategic entry point for wider patient adoption, particularly for patients who are hesitant to start injectable GLP-1 therapies or may struggle with long-term injection adherence, storage requirements, and administration fatigue